+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cluster Headache Market by Cluster Headaches Type (Chronic Cluster Headaches, Episodic Cluster Headaches), Drug Type (Anti-Seizure Drugs, Calcium Channel Blockers, Corticosteroids), Route of Administration, Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5968098
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cluster Headache Market grew from USD 381.04 million in 2023 to USD 401.80 million in 2024. It is expected to continue growing at a CAGR of 5.71%, reaching USD 562.38 million by 2030.

The cluster headache market includes pharmaceuticals (such as specific medications to alleviate symptoms or prevent headache onset), medical devices (such as oxygen therapy equipment), and various therapies and support services designed to help patients cope with this medical condition. The increase in reported cases or better diagnostic methods to identify the condition can lead to greater demand for treatments and services. Technological innovations in pharmaceuticals and medical technology directly impact the availability and effectiveness of treatments, potentially expanding the market scope. Regions with higher healthcare investment often see more robust market growth, primarily due to better treatment access. Increasing awareness about cluster headaches among the general public and healthcare professionals may lead to earlier diagnosis and treatment, driving the need for cluster headache treatment solutions. However, the high cost of treatment may limit the adoption of cluster headache products in underdeveloped countries. Regulatory hurdles may also create challenges for market growth. Moreover, developing treatments tailored to individual patient genetics or symptoms could improve efficacy and patient outcomes. Non-invasive stimulation devices offer a drug-free alternative for managing pain associated with cluster headaches, presenting a significant growth opportunity in upcoming years.

Regional Insights

In the Americas region, increasing focus on neurological disorders in the United States and Canada has led to the advancement in treatments and medications specifically targeting cluster headaches. The Americas market shows a high demand for innovative treatment solutions, driven by a well-established healthcare infrastructure and patient awareness programs. The EU countries show a strong inclination towards evidence-based treatments for cluster headaches, with a market driven by stringent regulatory standards and a high level of consumer awareness. In the Middle East and Africa, the market is gradually recognizing the importance of addressing cluster headaches amidst broader healthcare challenges. Initiatives aimed at healthcare professional education and the introduction of mobile health solutions are emerging, catering to a growing need for accessible and affordable treatments in the EMEA region. In the APAC region, the market is rapidly evolving, with a growing awareness of cluster headaches among healthcare professionals and patients. Consumer needs in China and India are gravitating toward affordable treatment options, accompanied by a surge in local pharmaceutical advancements targeting specific cluster headache treatments.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Cluster Headache Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Rising prevalence of cluster headaches worldwide
  • Ongoing research and development initiatives in pharmaceuticals and medical technology
  • Surging healthcare investments to advance treatment options

Market Restraints

  • Low awareness or misdiagnosis of cluster headaches

Market Opportunities

  • Advancements in personalized medicines tailored to individual patient genetics
  • Ongoing product approvals for newly developed cluster headache drugs

Market Challenges

  • Complex regulatory requirements for product approvals

Market Segmentation Analysis

  • Cluster Headaches Type: Increasing need for drugs to treat chronic cluster headache
  • Distribution Channel: Rising preference for online pharmacies for effective product penetration

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cluster Headache Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cluster Headache Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Amgen Expands Therapeutic Portfolio Through Strategic Acquisition of Horizon Therapeutics

Amgen has completed the acquisition of Horizon Therapeutics, marking a significant expansion in its market presence The acquisition aims at enhancing patient care globally by integrating Horizon's innovative, early-stage treatments for rare inflammatory diseases into Amgen's robust inflammation portfolio. The acquisition aligns with Amgen's mission to deliver groundbreaking medicines, leveraging its extensive biologics research, development expertise, and global reach to foster revenue growth and maintain financial health.

Tonix Pharmaceuticals Expands Migraine Treatment Portfolio with Strategic Acquisition

Tonix Pharmaceuticals Holding Corp., alongside its subsidiary Tonix Medicines, Inc., has finalized the acquisition of two established products from Upsher-Smith Laboratories, LLC: Zembrace SymTouch (a sumatriptan injection) and Tosymra (a sumatriptan nasal spray), both aimed at treating acute migraine in adults. This acquisition, marking a significant milestone in Tonix's journey towards becoming a fully integrated biopharmaceutical entity, underscores its growing expertise in central nervous system disorders.

FDA Approval of QULIPTA for Treatment of Chronic and Episodic Migraine

AbbVie, has received FDA approval to extend the use of QULIPTA (atogepant) as a preventive treatment for both episodic and chronic migraine in adults, marking a significant advancement in migraine management. With this, AbbVie strengthens its position by being the only company offering three distinct migraine treatments: QULIPTA for prevention in chronic and episodic cases, BOTOX for chronic migraine prevention, and UBRELVY for acute migraine attack management.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cluster Headache Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Cluster Headache Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amgen Inc., AstraZeneca plc, Biogen, Inc., Boehringer Ingelheim International GmbH, electroCore, Inc., Eli Lilly and Company, GlaxoSmithKline PLC, Lundbeck LLC, Lupin Limited, Pfizer Inc., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Cluster Headache Market to forecast the revenues and analyze trends in each of the following sub-markets:

Cluster Headaches Type

  • Chronic Cluster Headaches
  • Episodic Cluster Headaches

Drug Type

  • Anti-Seizure Drugs
  • Calcium Channel Blockers
  • Corticosteroids
  • Ergots
  • Lithium carbonate
  • Melatonin
  • Sumatriptan

Route of Administration

  • Intravenous
  • Oral
  • Topical

Distribution Channel

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of cluster headaches worldwide
5.1.1.2. Ongoing research and development initiatives in pharmaceuticals and medical technology
5.1.1.3. Surging healthcare investments to advance treatment options
5.1.2. Restraints
5.1.2.1. Low awareness or misdiagnosis of cluster headaches
5.1.3. Opportunities
5.1.3.1. Advancements in personalized medicines tailored to individual patient genetics
5.1.3.2. Ongoing product approvals for newly developed cluster headache drugs
5.1.4. Challenges
5.1.4.1. Complex regulatory requirements for product approvals
5.2. Market Segmentation Analysis
5.2.1. Cluster Headaches Type: Increasing need for drugs to treat chronic cluster headache
5.2.2. Distribution Channel: Rising preference for online pharmacies for effective product penetration
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Cluster Headache Market, by Cluster Headaches Type
6.1. Introduction
6.2. Chronic Cluster Headaches
6.3. Episodic Cluster Headaches
7. Cluster Headache Market, by Drug Type
7.1. Introduction
7.2. Anti-Seizure Drugs
7.3. Calcium Channel Blockers
7.4. Corticosteroids
7.5. Ergots
7.6. Lithium carbonate
7.7. Melatonin
7.8. Sumatriptan
8. Cluster Headache Market, by Route of Administration
8.1. Introduction
8.2. Intravenous
8.3. Oral
8.4. Topical
9. Cluster Headache Market, by Distribution Channel
9.1. Introduction
9.2. Hospital Pharmacies
9.3. Online Pharmacies
9.4. Retail Pharmacies
10. Americas Cluster Headache Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cluster Headache Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cluster Headache Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Amgen Expands Therapeutic Portfolio Through Strategic Acquisition of Horizon Therapeutics
13.3.2. Tonix Pharmaceuticals Expands Migraine Treatment Portfolio with Strategic Acquisition
13.3.3. FDA Approval of QULIPTA for Treatment of Chronic and Episodic Migraine
13.4. Strategy Analysis & Recommendation
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. CLUSTER HEADACHE MARKET RESEARCH PROCESS
FIGURE 2. CLUSTER HEADACHE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CLUSTER HEADACHE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CLUSTER HEADACHE MARKET DYNAMICS
FIGURE 7. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 14. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CLUSTER HEADACHE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CLUSTER HEADACHE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CLUSTER HEADACHE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. CLUSTER HEADACHE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CLUSTER HEADACHE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CLUSTER HEADACHE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CLUSTER HEADACHE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY CHRONIC CLUSTER HEADACHES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY CHRONIC CLUSTER HEADACHES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY EPISODIC CLUSTER HEADACHES, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY EPISODIC CLUSTER HEADACHES, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY ANTI-SEIZURE DRUGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY ANTI-SEIZURE DRUGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY CALCIUM CHANNEL BLOCKERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY ERGOTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY ERGOTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY LITHIUM CARBONATE, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY LITHIUM CARBONATE, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY MELATONIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY MELATONIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY SUMATRIPTAN, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY SUMATRIPTAN, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY TOPICAL, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY TOPICAL, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL CLUSTER HEADACHE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 55. ARGENTINA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 56. ARGENTINA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 57. ARGENTINA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 58. ARGENTINA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 63. BRAZIL CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 64. BRAZIL CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 65. BRAZIL CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 66. BRAZIL CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 67. BRAZIL CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 68. BRAZIL CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 69. BRAZIL CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 70. BRAZIL CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 71. CANADA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 72. CANADA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 73. CANADA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 74. CANADA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 75. CANADA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 76. CANADA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 77. CANADA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 78. CANADA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 79. MEXICO CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 80. MEXICO CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 81. MEXICO CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 82. MEXICO CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 83. MEXICO CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 84. MEXICO CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 85. MEXICO CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 86. MEXICO CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 87. UNITED STATES CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 88. UNITED STATES CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 89. UNITED STATES CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 90. UNITED STATES CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 91. UNITED STATES CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 92. UNITED STATES CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 93. UNITED STATES CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 94. UNITED STATES CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 95. UNITED STATES CLUSTER HEADACHE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 96. UNITED STATES CLUSTER HEADACHE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 98. ASIA-PACIFIC CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 100. ASIA-PACIFIC CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 102. ASIA-PACIFIC CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 104. ASIA-PACIFIC CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 106. ASIA-PACIFIC CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 107. AUSTRALIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 108. AUSTRALIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 109. AUSTRALIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 110. AUSTRALIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 111. AUSTRALIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 112. AUSTRALIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 113. AUSTRALIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 114. AUSTRALIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 115. CHINA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 116. CHINA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 117. CHINA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 118. CHINA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 119. CHINA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 120. CHINA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 121. CHINA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 122. CHINA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 123. INDIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 124. INDIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 125. INDIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 126. INDIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 127. INDIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 128. INDIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 129. INDIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 130. INDIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 131. INDONESIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 132. INDONESIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 133. INDONESIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 134. INDONESIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 135. INDONESIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 136. INDONESIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 137. INDONESIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 138. INDONESIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 139. JAPAN CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 140. JAPAN CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 141. JAPAN CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 142. JAPAN CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 143. JAPAN CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 144. JAPAN CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 145. JAPAN CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 146. JAPAN CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 147. MALAYSIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 148. MALAYSIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 149. MALAYSIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 150. MALAYSIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 151. MALAYSIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 152. MALAYSIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 153. MALAYSIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 154. MALAYSIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 155. PHILIPPINES CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 156. PHILIPPINES CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 157. PHILIPPINES CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 158. PHILIPPINES CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 159. PHILIPPINES CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 160. PHILIPPINES CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 161. PHILIPPINES CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 162. PHILIPPINES CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 163. SINGAPORE CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 164. SINGAPORE CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 165. SINGAPORE CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 166. SINGAPORE CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 167. SINGAPORE CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 168. SINGAPORE CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 169. SINGAPORE CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 170. SINGAPORE CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 171. SOUTH KOREA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 172. SOUTH KOREA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 173. SOUTH KOREA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 174. SOUTH KOREA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 175. SOUTH KOREA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 176. SOUTH KOREA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 177. SOUTH KOREA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 178. SOUTH KOREA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 179. TAIWAN CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 180. TAIWAN CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 181. TAIWAN CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 182. TAIWAN CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 183. TAIWAN CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 184. TAIWAN CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 185. TAIWAN CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 186. TAIWAN CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 187. THAILAND CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 188. THAILAND CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 189. THAILAND CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 190. THAILAND CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 191. THAILAND CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 192. THAILAND CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 193. THAILAND CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 194. THAILAND CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 195. VIETNAM CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 196. VIETNAM CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 197. VIETNAM CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 198. VIETNAM CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 199. VIETNAM CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 200. VIETNAM CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 201. VIETNAM CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 202. VIETNAM CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA CLUSTER HEADACHE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 213. DENMARK CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 214. DENMARK CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 215. DENMARK CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 216. DENMARK CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 217. DENMARK CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 218. DENMARK CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 219. DENMARK CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 220. DENMARK CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 221. EGYPT CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 222. EGYPT CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 223. EGYPT CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 224. EGYPT CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 225. EGYPT CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 226. EGYPT CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 227. EGYPT CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 228. EGYPT CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 229. FINLAND CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 230. FINLAND CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 231. FINLAND CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 232. FINLAND CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 233. FINLAND CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 234. FINLAND CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 235. FINLAND CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 236. FINLAND CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 237. FRANCE CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 238. FRANCE CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 239. FRANCE CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 240. FRANCE CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 241. FRANCE CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 242. FRANCE CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 243. FRANCE CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 244. FRANCE CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 245. GERMANY CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 246. GERMANY CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 247. GERMANY CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 248. GERMANY CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 249. GERMANY CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 250. GERMANY CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 251. GERMANY CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 252. GERMANY CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 253. ISRAEL CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 254. ISRAEL CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 255. ISRAEL CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 256. ISRAEL CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 257. ISRAEL CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 258. ISRAEL CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 259. ISRAEL CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 260. ISRAEL CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 261. ITALY CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 262. ITALY CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 263. ITALY CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 264. ITALY CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 265. ITALY CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 266. ITALY CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 267. ITALY CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 268. ITALY CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 269. NETHERLANDS CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 270. NETHERLANDS CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 271. NETHERLANDS CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 272. NETHERLANDS CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 273. NETHERLANDS CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 274. NETHERLANDS CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 275. NETHERLANDS CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 276. NETHERLANDS CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 277. NIGERIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 278. NIGERIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 279. NIGERIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 280. NIGERIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 281. NIGERIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 282. NIGERIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 283. NIGERIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 284. NIGERIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 285. NORWAY CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 286. NORWAY CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 287. NORWAY CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 288. NORWAY CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 289. NORWAY CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 290. NORWAY CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 291. NORWAY CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 292. NORWAY CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 293. POLAND CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 294. POLAND CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 295. POLAND CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 296. POLAND CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 297. POLAND CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 298. POLAND CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 299. POLAND CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 300. POLAND CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 301. QATAR CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 302. QATAR CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 303. QATAR CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 304. QATAR CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 305. QATAR CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 306. QATAR CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 307. QATAR CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 308. QATAR CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 309. RUSSIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 310. RUSSIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 311. RUSSIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 312. RUSSIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 313. RUSSIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 314. RUSSIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 315. RUSSIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 316. RUSSIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 318. SAUDI ARABIA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 320. SAUDI ARABIA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 321. SAUDI ARABIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 322. SAUDI ARABIA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 323. SAUDI ARABIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 324. SAUDI ARABIA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 326. SOUTH AFRICA CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 328. SOUTH AFRICA CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 330. SOUTH AFRICA CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 332. SOUTH AFRICA CLUSTER HEADACHE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 333. SPAIN CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2018-2023 (USD MILLION)
TABLE 334. SPAIN CLUSTER HEADACHE MARKET SIZE, BY CLUSTER HEADACHES TYPE, 2024-2030 (USD MILLION)
TABLE 335. SPAIN CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2018-2023 (USD MILLION)
TABLE 336. SPAIN CLUSTER HEADACHE MARKET SIZE, BY DRUG TYPE, 2024-2030 (USD MILLION)
TABLE 337. SPAIN CLUSTER HEADACHE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
TABLE 338. S

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Amgen Inc.
  • AstraZeneca plc
  • Biogen, Inc.
  • Boehringer Ingelheim International GmbH
  • electroCore, Inc.
  • Eli Lilly and Company
  • GlaxoSmithKline PLC
  • Lundbeck LLC
  • Lupin Limited
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages181
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 401.8 Million
Forecasted Market Value ( USD ) by 2030 $ 562.38 Million
Compound Annual Growth Rate5.7%
Regions CoveredGlobal

Related Topics

Related Reports

Cluster Headache Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Cluster Headache Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 131 Pages
  • Global
From
Cluster Headache - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Cluster Headache - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Cluster Headache - Pipeline Insight, 2024 - Product Image

Cluster Headache - Pipeline Insight, 2024

  • Drug Pipelines
  • 60 Pages
  • Global
From
Cluster Headache Syndrome Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Cluster Headache Syndrome Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 99 Pages
  • Global
From
Pain Management - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Pain Management - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 115 Pages
  • Global
From

About the Cluster Headache Syndrome Drug Market

Cluster Headache Syndrome (CHS) is a rare neurological disorder characterized by severe, debilitating headaches. It is estimated to affect approximately 0.1% of the population. Treatment for CHS is typically divided into two categories: acute and preventive. Acute treatments are used to provide immediate relief from the pain of a cluster headache attack, while preventive treatments are used to reduce the frequency and severity of attacks. The Cluster Headache Syndrome Drug market is a subset of the Central Nervous System Drugs market. It is composed of pharmaceuticals used to treat CHS, including triptans, ergot alkaloids, and corticosteroids. These drugs are typically administered orally, intranasally, or subcutaneously. The Cluster Headache Syndrome Drug market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include GlaxoSmithKline, Pfizer, Novartis, Merck, and Sanofi. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.